This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary.
Crista's passion for advocacy began when her youngest son, Colton, was diagnosed with intractable epilepsy just after he turned two. Crista Eggers is deeply committed to the advocacy and advancement of medical cannabis legalization in Nebraska.
Epilepsy is a complex neurological disorder that affects millions of people worldwide, causing recurrent seizures that can significantly impact the quality of life. While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients.
The lawsuit, which was filed by a 19-year-old patient who uses cannabis for the treatment of severe epilepsy, argues that the proposed changes will unduly restrict medical cannabis access among patients and will discourage physicians from participating in the program.
Patients who suffer from epilepsy , which affects some 3.4 This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. CBD, which constitutes a $2,770.8
Epilepsy, Cannabis And The Newest Research. In a new study, researchers found that an autoantibody, which works against the body, seems to be responsible for causing epilepsy in some patients. . The post Epilepsy, Cannabis And The Newest Research appeared first on The Fresh Toast.
Of course, what matters most to patients and clinicians is whether topical and transdermal cannabinoids really work. It reviews about half a dozen such studies, plus another ten looking at transdermal CBD for other conditions, including drug addiction, neurodegeneration, skin cancer, wound healing, and epilepsy.
An expanding number of patients are utilizing marijuana for clinical reasons. The post Medical Marijuana shows promising results in treatment of Epilepsy first appeared on Cannabis Law Report. Use of Cannabis for treatment of medical conditions is gaining wide acceptance all over … Read More.
The proposed constitutional amendment establishes a state-licensed system of dispensaries to provide cannabis products to qualifying patients. The proposed initiative permits qualifying patients to possess up to 2.5 ounces (71 grams) of cannabis per 14-day period. But the law provides no legal supply source for such products.
I became passionate about medical cannabis when I saw remarkable results using cannabis in treating my son Zach’s severe refractory epilepsy. I started volunteering some time for Americans for Safe Access (ASA) , the country’s largest non-profit patient advocacy organization promoting safe and legal access to medical cannabis.
Qualified patients are anticipated to finally begin accessing medical cannabis products next week, according to a statement issued by regulators at the state’s Department of Agriculture and Forestry (LDAF). The first products to be available to patients are cannabis-infused tinctures.
Florida law allows eligible residents to receive medical marijuana treatment for specific medical issues, including ALS, cancer, Crohn’s Disease, Epilepsy, Glaucoma, HIV/AIDS, Multiple Sclerosis, Parkinson’s Disease, PTSD, and more. While some are only concerned with transport in […]
Newly sworn-in Governor Ron DeSantis officially ended the statewide ban on smokable forms of medical cannabis in Florida, making good on the promise he made to patients. In doing so, medical cannabis patients are finally legally permitted to smoke dried cannabis flower if their doctor recommends that specific method of administration.
However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Seizures, including those characteristic of epilepsy.
The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. The positive impact it’s having on the lives of patients across West Virginia is significant. MMJ can help patients achieve better sleep patterns and improved overall health.
Assembly Bill 20 , The Jake Honig Compassionate Use Medical Cannabis Act, institutes various changes to the program to better facilitate patients’ access to the substance. Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy.
The bill provides for the production and distribution of a limited variety of medical cannabis products to qualified patients, including those with PTSD, cancer, chronic pain, epilepsy or any other intractable seizure disorder; multiple sclerosis, muscle spasms, or spasticity; and nausea or vomiting. .
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.
However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. ECS modulation also aids in managing symptoms of nausea and vomiting in cancer patients undergoing chemotherapy. What is ECS?
I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? Although products containing 0.3% A simple question.
Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.
A newly published article in the Epilepsy & Behavior Journal highlights the findings of researchers at the University of Alabama at Birmingham after surveying healthcare providers on their attitudes and knowledge about cannabis, and has confirmed what most of us already knew– healthcare providers need more education on cannabis.
Mary Schneider (D) cleared the House in an 86-6 vote this March, allowing terminally ill patients to use proof of their admittance in hospice care in lieu of a doctor’s written recommendation to register as a medical cannabis patient. This is also the process for those who are treating patients that are terminally ill.
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.
The proposed constitutional amendment seeks to permit qualified patients to obtain medical cannabis products at state-licensed facilities. ” Under Mississippi law, the possession of cannabis for medical purposes is illegal except for the use of certain CBD extracts in patients with pediatric epilepsy.
Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. These compounds may help reduce symptoms and improve the quality of life for patients. The outcomes of these studies have had a profound impact on patient care.
Fifty-nine-year old Dragoljub Mrdjic has suffered from epilepsy for most of his life. Patients are in a terrible situation. Few medicines have helped him, but his condition drastically improved after he started treating himself with cannabis oil in 2001. “I I tried standard medicine, but there wasn’t much of a result.
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.
Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.
The Lone Star State is so strict that only epilepsypatients can obtain CBD oil. But some companies are investing for the long haul. The post Here’s What Medical Cannabis Looks Like in Texas appeared first on Leafly.
This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.
4) Reduces Seizures in Epilepsy Medical cannabis can be used to manage seizures in people with epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures. Traditional treatments for epilepsy, such as anti-convulsant medications, are not effective for everyone and can have significant side effects.
Once medical marijuana is ingested, the receptors are opened and the medication begins to provide relief to patients. When a patient consumes medical marijuana they are essentially supplementing their naturally-occurring endocannabinoid system. The endocannabinoid system consists of cannabinoid receptors all over the body. Crohn’s. .
Faveret became one of the first physicians in Brazil to prescribe medical cannabis extract to a child, subsequently treating more than 3,000 patients with conditions such as Alzheimer’s, Parkinson’s, MS, cancer, anxiety, depression, insomnia, Tourette’s syndrome, autism, and chronic pain, among others.
According to the Texas Government site, Texass Compassionate Use Program (CUP) allows certain physicians to prescribe low tetrahydrocannabinols (THC) cannabis for medical purposes. The Texas medical cannabis program allows for no more than 0.5%
GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)
Lawmakers have been listening to constituents suffering from debilitating diseases, like epilepsy and cancer, who say they would like to have the option to explore how medical cannabis may ease their symptoms. Cassie Everett, a woman from Louisville who suffers from epilepsy contacted Rep. Why Medical Marijuana? Nemes said.
MEDICINAL CANNABIS WILL BE LEGALIZED FOR PATIENTS TO WIN A PAIN-FREE DAY. The greatest achievement in the opinion of the President of the National Assembly, Crispiano Adames, “is the relief that patients will have because they deserve it.” Here’s what’s been published by the Panamanian Assembly (Monday).
CBD-based treatment for people with Refractory Epilepsy?—?is According to the World Health Organisation (WHO), there are approximately 50 million people currently living with a form of Epilepsy throughout the world, and of those 50 million, 30% have Refractory Epilepsy. is the first product we’ve released to market.
Epidiolex was approved specifically for treating patients suffering from seizures associated with Dravet Syndrome, which is a severe form of epilepsy that affects between 20,000 and 40,000 people worldwide. Though these tumors are noncancerous in nature, their presence can cause health problems, including epilepsy.
LifeCannMD was founded by Dr. Fernando Fandiño-Sende in Miami, and is dedicated to the evaluation, education, and treatment of patients who qualify for Medical Cannabis, since June 2017, Florida residents with certain qualifying conditions can obtain a Medical Marijuana recommendation for treatment.
However, there are some patients who don’t respond well to these types of treatments or simply prefer to try alternative therapies like medical cannabis instead. One thing we do know is that CBD may be promising for some patients with MG, as it has been shown to reduce muscle tightness and weakness. Could marijuana be the answer?
Legislation that would have significantly expanded patient access to medical cannabis in Rhode Island was held in a senate committee for further study, ultimately killing the bill. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.
In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content